Navigation Links
New Drug Found To Improve Driving Performance In Young Adults With ADHD

A new drug, ADDERALL XR? has been found to improve driving performance, cognitive function and attention in young adults with attention-deficit/hyperactivity disorder (ADHD).//

The result has been presented at the 18th Annual U.S. Psychiatric & Mental Health Congress in Las Vegas, NV and establishes that the drug helps young adults improve their ability to drive over a 12-hour period.

Accidents are the leading cause of death until age 40, the incidence of which is greater among adults with ADHD. Furthermore, the incidence of traffic violations and license suspensions is much greater than among patients with ADHD.

Infact, ADHD patients were five times more likely to have speeding tickets (5 or more) and three times more likely to succumb to vehicular clashes (thrice or more). This observation could be because of the fact that adolescent and adult patients often fail to appreciate the effect that ADHD symptoms such as inattention have on daily activities such as driving.

The researchers hence studied the effect of ADDERALL XR, a major ADHD therapy, on driving performance in young adult patients with ADHD. Participants received doses of ADDERALL XR at 20 milligrams (mg) for the first week and then increased to 40 mg and 50 mg for the second and third weeks, respectively.

All patients were evaluated for driving performance after the medication was administered. The STISIM was used to analyze the critical driving skills, including situation awareness, hazard perception, risk assessment and decision-making under time pressure.

Patients taking the drug demonstrated significant improvement in driving safety and performance compared to a placebo. Safety-related driving parameters, including speeding tickets, traffic tickets, crashes, crash avoidance rating, time to collision and excess speed were some of the factors taken into consideration during the assessment.

Furthermore, ADDERALL XR significantl y improved ADHD symptom control in young adults with ADHD as compared to those on placebo. Eighty percent of patients experienced at least a 30 percent reduction in their ADHD symptoms. It also had significant effects on the participants' attention, an important cognitive ability.

The majority of side effects during the trial were mild or moderate and consistent with known side effects of stimulant medications such as decreased appetite, weight loss, dry mouth, insomnia and bruxism (teeth grinding). These findings suggest that there is a carryover beneficial effect of having performed a mentally demanding task like driving. The effect would even be valuable when the individual is not taking the medication.
'"/>




Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... of the much-anticipated fall event , Look Awesome This Autumn with CoolSculpting®. ... consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique is Houston’s ...
(Date:9/20/2017)... ... 20, 2017 , ... Each year Athletic Trainers from around ... Association Annual Clinical Symposium and Expo. New research is revealed, evidence based practice ... are acknowledged by their peers with accolades and highly prestigious awards. This past ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Americans at risk of price gouging for their prescription drugs, according to a ... “Because Medicare isn’t negotiating on our behalf, there’s no consistency in drug pricing ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story ... average life. This mouse sets out on a journey that will show that friends ... the creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; Second ... of God; Second Edition” is the creation of published author, Brooks Rathell. , “We ... to talk to you about the financial favor of God. Not only does it ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
Breaking Medicine Technology: